Suppr超能文献

前沿:CD83调节细胞免疫的发育。

Cutting edge: CD83 regulates the development of cellular immunity.

作者信息

Scholler Nathalie, Hayden-Ledbetter Martha, Dahlin Amber, Hellström Ingegerd, Hellström Karl Erik, Ledbetter Jeffrey A

机构信息

Laboratories of. Tumor Immunology, and Immunobiology, Pacific Northwest Research Institute, Seattle, WA 98122, USA.

出版信息

J Immunol. 2002 Mar 15;168(6):2599-602. doi: 10.4049/jimmunol.168.6.2599.

Abstract

We recently found that human CD83, a marker of mature dendritic cells, is an adhesion receptor that binds to resting monocytes and a subset of activated CD8(+) T cells. We injected CD83-Ig into mice transplanted with the immunogenic P815 mastocytoma and showed that it significantly enhanced the rate of tumor growth and inhibited the development of cytotoxic T cells. In contrast, mice immunized with CD83-transfected K1735 cells, a poorly immunogenic melanoma, could prevent the outgrowth of wild-type K1735 cells. Studies performed in vitro with human PBL showed that coimmobilized CD83-Ig and anti-CD3 enhanced T cell proliferation and increased the proportion of CD8(+) T cells. CD83-transfected B-lymphoblastoid T51 cells stimulated T cell proliferation more effectively than untransfected T51 cells in MLR cultures and increased the generation of cytolytic T cells. We conclude that CD83 is a functionally important receptor that can regulate the development of cellular immunity by interacting with its ligand(s).

摘要

我们最近发现,人类CD83作为成熟树突状细胞的标志物,是一种粘附受体,可与静息单核细胞及一部分活化的CD8(+) T细胞结合。我们将CD83-Ig注射到移植了免疫原性P815肥大细胞瘤的小鼠体内,结果显示它显著提高了肿瘤生长速率,并抑制了细胞毒性T细胞的发育。相比之下,用CD83转染的K1735细胞(一种免疫原性较差的黑色素瘤)免疫的小鼠能够阻止野生型K1735细胞的生长。用人外周血淋巴细胞进行的体外研究表明,共固定的CD83-Ig和抗CD3可增强T细胞增殖,并增加CD8(+) T细胞的比例。在混合淋巴细胞反应培养中,CD83转染的B淋巴母细胞T51细胞比未转染的T51细胞更有效地刺激T细胞增殖,并增加细胞毒性T细胞的生成。我们得出结论,CD83是一种功能上重要的受体,可通过与其配体相互作用来调节细胞免疫的发育。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验